The studies have suggested that dopamine D3 receptor antagonists could improve cognitive function of rats, which may be helpful in the clinical treatment of cognitive dysfunction associated with psychiatric disorders (Laszy et al., 2005; Watson et al., 2012). The gene discussed is DRD3; the disease is psychiatric disorder.